Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004991857 | SCV005602388 | uncertain significance | Cardiovascular phenotype | 2024-11-27 | criteria provided, single submitter | clinical testing | The c.625_645del21 variant (also known as p.E209_P215del), located in coding exon 2 of the JPH2 gene, results from an in-frame GAGGCGGCCGCGCGGGCGCCC deletion at nucleotide positions 625 to 645. This results in the in-frame deletion 7 amino acids at codons 209 to 215. This amino acid region is not well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Based on the available evidence, the clinical significance of this variant remains unclear. |